Posts Tagged ‘diabetes mellitus

HDL also seems to be more quickly hydrolyzed in patients with insulin resistance, leading to lower HDL levels. Statins can reduce LDL levels by 18% to 55% and triglycerides by 7% to 30%; they can also increase HDL levels by 5% to 15%.

The number of people living with diabetes mellitus in the U.S. has crossed the 20 million mark, with 1.5 million cases having been diagnosed in 2005 alone. Because nearly 65% of this population will suffer from heart disease or stroke, it is crucial for health care professionals to continually investigate the efficacy of current diabetes […]

Our findings support the growing concern about problems of overweight and obesity among school-age children and the need to use BMI as a percentile according to sex and age to properly evaluate such students. Because our study sample was mostly black students, we will focus on concerns about this portion of the U.S. population. Of […]

Table 2 outlines the demographics of each of the five classes assessed. Data were obtained from the Nutstat module of Epi Info.6 The ages in months for each grade reflect that this study was completed in the spring of the academic school year. Because the 54 black students made up more than 80% of the […]

After receiving parental permission, 66 children from grades one through five in the City of Richmond’s first model elementary school were assessed for height and weight (counterweight scale) by the school nurse on March 14, 2003. Students wore their school dress, took off their shoes, and emptied their pockets before being weighed. Additional demographic information […]

INTRODUCTION Obesity is an ever-increasing problem in the United States. Recent reports describe a 30.5% age-adjusted prevalence rate of obesity for adults. Comparable figures for children and adolescents are 10.4% for ages 2-5 years, 15.3% for ages 6-11 years, and 15.5% for ages 12-19 years.

Thiazolidinediones Another area of investigation concerns the role of the thiazolidinediones in CVD prevention. Rosigli­tazone, a peroxisome proliferator-activated receptor (PPAR)-g agonist that is used in the treatment of type-2 diabetes, is also known to have anti-inflammatory effects. In 84 patients with stable, angio-graphically documented CAD and no diabetes who were randomized to rosiglitazone or placebo […]